News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO
Photo from ESMO/LinkedIn
Jul 5, 2024, 02:30

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

ESMO shared on LinkedIn:

“Benefits reported for the combination of ipilimumab and nivolumab further expand alternative therapeutic options for patients with unresected advanced Hepatocellular Carcinoma.
Read the opinion piece by Angela Lamarca on ESMO Daily Reporter.”

Source: ESMO/LinkedIn

.

Angela Lamarca cancer ESMO ESMO Daily Reporter hepatocellular carcinoma ipilimumab nivolumab OncoDaily Oncology
Special Coverage
Blog
Apr 19, 2025, 21:04
Jasmine Kamboj Hosts Policy Webinar with Expert Panel on May 2
Blog
Apr 19, 2025, 20:48
Palliative Care Knowledge in ICUs: Bilal Awad Publishes Q1 Research
Blog
Apr 19, 2025, 20:25
Breast Density Reporting Urged by Lobular Ireland Founder Siobhan Freeney
Blog
Apr 19, 2025, 20:05
Suzette DiMascio: I reflect on a moment that changed my life - and helped save another
Blog
Apr 19, 2025, 19:36
Pranati Yadlapalli Presents Nerve Injury Research at National Conference
Blog
Apr 19, 2025, 19:17
Yelak Biru: Rahul Banerjee on redefining 'cure' in myeloma
Science
Apr 19, 2025, 19:01
Stephen Liu: Perspective on unintended consequences of patient portal access
Blog
Apr 19, 2025, 18:46
Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing
Blog
Apr 19, 2025, 18:42
Pediatric Exercise Oncology Conference 2026: Save the Date - FORTEe
Insight
Apr 19, 2025, 18:29
ESMO living guidelines on metastatic breast cancer
Blog
Apr 19, 2025, 18:20
Todd Davis: Ligand Pharmaceuticals announces agreement to combine Pelthos with Channel Therapeutics
Blog
Apr 19, 2025, 18:05
Prasad Raj Dandekar: A detailed conversation about immunotherapy with Sewanti Limaye